Isolation of adipose-derived stem cells: a comparison among different methods

Adipose-derived stromal cells are widely used in regenerative medicine. Collagenase digestion is a standard method for isolating these cells. However, collagenase is expensive and may not be the most cost-effective option. Prior research has shown that alternative enzymes and protocols can yield viable cell populations. The economic viability of cell isolation methods is a key concern in tissue engineering. No prior work had resolved whether trypsin could replace collagenase effectively. This gap motivated a direct comparison of multiple digestion methods. The goal was to identify a more affordable yet efficient approach. This study contributes by evaluating nine protocols for ASC isolation.

The aim of this study was to compare nine different methods for isolating adipose-derived stromal cells. A primary objective was to identify a cost-effective alternative to collagenase digestion. The researchers focused on evaluating isolation rate, cell viability, and expansion capacity. They also assessed immunophenotype and differentiation potential. The motivation stemmed from the high cost of collagenase in standard protocols. This study sought to determine whether trypsin could serve as a viable substitute. The comparison included methods involving lysis buffer, trypsin, and centrifugation. The ultimate goal was to recommend a more economically viable protocol.

Nine isolation protocols were tested using adipose tissue samples. Each method involved different combinations of lysis buffer, trypsin, collagenase, and centrifugation. The isolation rate was measured to assess efficiency. Cell viability was evaluated using standard assays. Expansion rate was tracked over several passages in culture. Immunophenotype was analyzed using flow cytometry. Adipogenic and osteogenic differentiation were tested in vitro. The protocols were compared based on cost and functional outcomes.

Trypsin digestion yielded a higher isolation rate than collagenase. Cell viability remained above 80% in all tested protocols. The expansion rate was comparable across methods. Immunophenotype results showed similar surface marker profiles. Adipogenic differentiation was consistent between groups. Osteogenic differentiation was up to seven times higher with trypsin. This suggests trypsin enhances bone lineage potential. The trypsin-based protocol was more cost-effective than collagenase methods.

The authors found that trypsin digestion is a viable alternative to collagenase. This method supports efficient ASC isolation with high viability. The osteogenic differentiation capacity was significantly higher. The trypsin-based protocol is more economically viable. These findings suggest a promising approach for bone tissue engineering. The study does not claim trypsin is essential for all ASC applications. The results align with the goal of cost-effective cell isolation. The authors propose that this protocol could be adopted in tissue engineering contexts.